Document
IPR2017-01995, No. 2020-110 Exhibit - Oct 25, 2017 Deposition Testimony of Brian Ault, PhD in the Horizon Pharma, Inc v Dr Reddy¿¿¿s Laboratories, Inc, Case No 315 cv 03324 DNJ PROTECT...
Cite Document
IPR2017-01995, No. 2020-110 Exhibit - Oct 25, 2017 Deposition Testimony of Brian Ault, PhD in the Horizon Pharma, Inc v Dr Reddy¿¿¿s Laboratories, Inc, Case No 315 cv 03324 DNJ PROTECTIVE ORDER MATER
+ More Snippets
Document
IPR2017-01995, No. 2027-66 Exhibit - IPR2017 01995, May 25, 2018 Deposition Transcript of David C Metz (P.T.A.B. Jun. 1, 2018)
Cite Document
IPR2017-01995, No. 2027-66 Exhibit - IPR2017 01995, May 25, 2018 Deposition Transcript of David C Metz (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2065-101 Exhibit - JL Goldstein et al, Impact of adherence to concomitant gastroprotective therapy on nonsteroidal related gastroduodenal ulcer complications, Clin Gastroe...
Cite Document
IPR2017-01995, No. 2065-101 Exhibit - JL Goldstein et al, Impact of adherence to concomitant gastroprotective therapy on nonsteroidal related gastroduodenal ulcer complications, Clin Gastroenterol He
+ More Snippets
Document
IPR2017-01995, No. 2032-69 Exhibit - Email string from Tore Lind to Richard Leff, Doug Levine, David Magner, and Mark Sostek, dated May 27, 2006 to May 31, 2006 (P.T.A.B. Jun. 1, 2018)
Cite Document
IPR2017-01995, No. 2032-69 Exhibit - Email string from Tore Lind to Richard Leff, Doug Levine, David Magner, and Mark Sostek, dated May 27, 2006 to May 31, 2006 (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2038-75 Exhibit - Prilosec Label (P.T.A.B. Jun. 1, 2018)
Cite Document
IPR2017-01995, No. 2038-75 Exhibit - Prilosec Label (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2044-81 Exhibit - FE Silverstein et al, Gastrointestinal toxicity with celecoxib vs nonsteroidal anti inflammatory drugs for osteoarthritis and rheumatoid arthritis the CLASS stu...
Cite Document
IPR2017-01995, No. 2044-81 Exhibit - FE Silverstein et al, Gastrointestinal toxicity with celecoxib vs nonsteroidal anti inflammatory drugs for osteoarthritis and rheumatoid arthritis the CLASS study
+ More Snippets
Document
IPR2017-01995, No. 2046-83 Exhibit - G Singh, Gastrointestinal complications of prescription and over the counter nonsteroidal anti inflammatory drugs a view from the ARAMIS database, Am J...
Cite Document
IPR2017-01995, No. 2046-83 Exhibit - G Singh, Gastrointestinal complications of prescription and over the counter nonsteroidal anti inflammatory drugs a view from the ARAMIS database, Am J Ther, 71151
+ More Snippets
Document
IPR2017-01995, No. 2058-94 Exhibit - SH Roth, NSAID gastropathy A new understanding, Arch Intern Med 15616231628 1996 (P.T.A.B. Jun. 1, 2018)
Cite Document
IPR2017-01995, No. 2058-94 Exhibit - SH Roth, NSAID gastropathy A new understanding, Arch Intern Med 15616231628 1996 (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2045-82 Exhibit - C Bombardier et al, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N Engl J Med, 343211520...
Cite Document
IPR2017-01995, No. 2045-82 Exhibit - C Bombardier et al, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N Engl J Med, 3432115201528 2000
+ More Snippets
Document
IPR2017-01995, No. 2016 Exhibit - Jan 24, 2018 Deposition Testimony of Dr John R Plachetka in the Horizon Pharma, Inc v Dr Reddy¿¿¿s Laboratories, Inc, Case No 315 cv 03324 DNJ PROTECT...
Cite Document
IPR2017-01995, No. 2016 Exhibit - Jan 24, 2018 Deposition Testimony of Dr John R Plachetka in the Horizon Pharma, Inc v Dr Reddy¿¿¿s Laboratories, Inc, Case No 315 cv 03324 DNJ PROTECTIVE ORDER MATER
+ More Snippets
Document
IPR2017-01995, No. 2025 Exhibit - Declaration of David R Taft PHD In Support of Patent Owner Response to Petition for Inter Partes Review of US Patent No 9,220,698 (P.T.A.B. Jun. 1, 2018)
Cite Document
IPR2017-01995, No. 2025 Exhibit - Declaration of David R Taft PHD In Support of Patent Owner Response to Petition for Inter Partes Review of US Patent No 9,220,698 (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2075 Exhibit - Ex 2075 MSJ Opinion (P.T.A.B. Feb. 8, 2019)
Cite Document
IPR2017-01995, No. 2075 Exhibit - Ex 2075 MSJ Opinion (P.T.A.B. Feb. 8, 2019)
+ More Snippets
Document
IPR2017-01995, No. 2024 Exhibit - January 30, 2013 Amendment C and Response to Final Office Action, Application No 12553,107 (P.T.A.B. Jun. 1, 2018)
Cite Document
IPR2017-01995, No. 2024 Exhibit - January 30, 2013 Amendment C and Response to Final Office Action, Application No 12553,107 (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2061 Exhibit - Wolfe et al, Gastroprotective therapy and risk of gastrointestinal ulcers risk reduction by COX 2 therapy, J Rheumatol 293467 473 2002 (P.T.A.B. Jun. 1, 2018...
Cite Document
IPR2017-01995, No. 2061 Exhibit - Wolfe et al, Gastroprotective therapy and risk of gastrointestinal ulcers risk reduction by COX 2 therapy, J Rheumatol 293467 473 2002 (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2012 Exhibit - Gabriel, SE, et al, Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti inflammatory Drugs, Annals of Internal Medicine, Vol 115...
Cite Document
IPR2017-01995, No. 2012 Exhibit - Gabriel, SE, et al, Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti inflammatory Drugs, Annals of Internal Medicine, Vol 115, No 1
+ More Snippets